These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 30264282)
1. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials. Rossello X; Ariti C; Pocock SJ; Ferreira JP; Girerd N; McMurray JJV; Van Veldhuisen DJ; Pitt B; Zannad F Clin Res Cardiol; 2019 May; 108(5):477-486. PubMed ID: 30264282 [TBL] [Abstract][Full Text] [Related]
2. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients. Peck KY; Lim YZ; Hopper I; Krum H Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548 [TBL] [Abstract][Full Text] [Related]
3. Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials. Bapoje SR; Bahia A; Hokanson JE; Peterson PN; Heidenreich PA; Lindenfeld J; Allen LA; Masoudi FA Circ Heart Fail; 2013 Mar; 6(2):166-73. PubMed ID: 23403436 [TBL] [Abstract][Full Text] [Related]
4. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767 [TBL] [Abstract][Full Text] [Related]
5. Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. Adamopoulos C; Ahmed A; Fay R; Angioi M; Filippatos G; Vincent J; Pitt B; Zannad F; Eur J Heart Fail; 2009 Nov; 11(11):1099-105. PubMed ID: 19875410 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials. Rossello X; Ferreira JP; Pocock SJ; McMurray JJV; Solomon SD; Lam CSP; Girerd N; Pitt B; Rossignol P; Zannad F Eur J Heart Fail; 2020 May; 22(5):834-844. PubMed ID: 32077220 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction: A meta-analysis of randomized controlled trials. Xu Y; Qiu Z; Yang R; Wu Y; Cheng X Medicine (Baltimore); 2018 Dec; 97(51):e13690. PubMed ID: 30572494 [TBL] [Abstract][Full Text] [Related]
8. Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial. Carillo S; Zhang Y; Fay R; Angioi M; Vincent J; Sutradhor SC; Ahmed A; Pitt B; Zannad F Arch Cardiovasc Dis; 2014 Mar; 107(3):149-57. PubMed ID: 24630753 [TBL] [Abstract][Full Text] [Related]
9. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
10. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668 [TBL] [Abstract][Full Text] [Related]
11. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS. O'Keefe JH; Abuissa H; Pitt B Diabetes Obes Metab; 2008 Jun; 10(6):492-7. PubMed ID: 17490427 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607 [TBL] [Abstract][Full Text] [Related]
14. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Gheorghiade M; Khan S; Blair JE; Harinstein ME; Krum H; Mukherjee R; Pitt B; Am Heart J; 2009 Sep; 158(3):437-43. PubMed ID: 19699868 [TBL] [Abstract][Full Text] [Related]
15. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF. Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796 [TBL] [Abstract][Full Text] [Related]
16. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M; N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699 [TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials. Pamporis K; Karakasis P; Sagris M; Zarifis I; Bougioukas KI; Pagkalidou E; Milaras N; Samaras A; Theofilis P; Fragakis N; Tousoulis D; Xanthos T; Giannakoulas G Curr Probl Cardiol; 2024 Jul; 49(7):102615. PubMed ID: 38692445 [TBL] [Abstract][Full Text] [Related]
18. Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns. Ferreira JP; Duarte K; McMurray JJV; Pitt B; van Veldhuisen DJ; Vincent J; Ahmad T; Tromp J; Rossignol P; Zannad F Circ Heart Fail; 2018 Jul; 11(7):e004926. PubMed ID: 29997240 [TBL] [Abstract][Full Text] [Related]